Being able to experiment early (even if it seems crazy) is not just intellectually rewarding, but often financially as well, across all domains. This is how I ended up buying NYSE: LLY in 2022.
I started my first GLP-1 injection in 2020 (stopped after 3 months, i shared on @DoveyAgeX abt the rationale). By 2022, after researching their novel dual GIP/GLP-1 receptor agonist before FDA approval, I bought NYSE: LLY. The rationale was simple: the hype comp with semaglutide made LLY a high ev bet and LLY is the only one in the dual camp. Over the past two yrs, LLY outperformed, becoming the top healthcare stock, surpassing legacy pharma companies, and joining the trillion-dollar club as the first in pharma.
If you think of your investing skillset as a pyramid, the base is built on strong curiosity and endless interest ti figure out why things happen and why now. Only with a wide enough base can the pyramid rise high.
The cure for boredom is curiosity, but there is no cure for curiosity. I LOVE all my crazy experiments so far, life’s too short to be bored.